Erika L. Eves
2020
In 2020, Erika L. Eves earned a total compensation of $178.2K as Vice President, Finance & Administration at Navidea Biopharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $21,042 |
|---|---|
| Option Awards | $4,588 |
| Salary | $147,325 |
| Other | $5,273 |
| Total | $178,228 |
Eves received $147.3K in salary, accounting for 83% of the total pay in 2020.
Eves also received $21K in non-equity incentive plan, $4.6K in option awards and $5.3K in other compensation.
Rankings
In 2020, Erika L. Eves' compensation ranked 12,664th out of 13,090 executives tracked by ExecPay. In other words, Eves earned more than 3.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,664 out of 13,090 | 3rd |
Division Manufacturing | 5,431 out of 5,621 | 3rd |
Major group Chemicals And Allied Products | 2,194 out of 2,254 | 3rd |
Industry group Drugs | 1,906 out of 1,954 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 58 out of 60 | 3rd |
Source: SEC filing on October 24, 2022.
Eves' colleagues
We found three more compensation records of executives who worked with Erika L. Eves at Navidea Biopharmaceuticals in 2020.